Dr. Morgan Willming is a toxicologist with diverse experience in environmental and human health risk assessment, per- and polyfluoroalkyl substance (PFAS) regulatory toxicology, consumer product safety assessment, toxicity analysis and prediction, and risk communication. She has helped clients in the consumer products industry, chemical trade associations, pharmaceutical industry, and the legal sector interpret toxicological data and evaluate regulatory requirements of FDA, EPA, and international regulatory authorities. She brings strategic problem solving and technical communication skills to address challenges related to toxicology and risk assessment. Her experience in developing multisector partnerships has facilitated improved stakeholder coordination to address emerging chemical risks.
Ph.D., Environmental Toxicology, Texas Tech University, Lubbock, Texas, 2014
B.S. Biology, Hope College, Holland, Michigan, 2009
Diplomate of the American Board of Toxicology (DABT), since 2023
Hazardous Waste Operations and Emergency Response 40‑Hour Certification (2021)
Member of the Society of Toxicology (SOT)
Member of the Society of Environmental Toxicology and Chemistry (SETAC)
Morgan Willming, Ph.D., DABT Consultant
Dr. Morgan Willming is a toxicologist with diverse experience in environmental and human health risk assessment, per- and polyfluoroalkyl substance (PFAS) regulatory toxicology, consumer product safety assessment, toxicity analysis and prediction, and risk communication. She has helped clients in the consumer products industry, chemical trade associations, pharmaceutical industry, and the legal sector interpret toxicological data and evaluate regulatory requirements of FDA, EPA, and international regulatory authorities. She brings strategic problem solving and technical communication skills to address challenges related to toxicology and risk assessment. Her experience in developing multi...
Dr. Morgan Willming is a toxicologist with diverse experience in environmental and human health risk assessment, per- and polyfluoroalkyl substance (PFAS) regulatory toxicology, consumer product safety assessment, toxicity analysis and prediction, and risk communication. She has helped clients in the consumer products industry, chemical trade associations, pharmaceutical industry, and the legal sector interpret toxicological data and evaluate regulatory requirements of FDA, EPA, and international regulatory authorities. She brings strategic problem solving and technical communication skills to address challenges related to toxicology and risk assessment. Her experience in developing multisector partnerships has facilitated improved stakeholder coordination to address emerging chemical risks.
Building a Safe Energy Future: Proactive Product Stewardship for Battery Storage
Resource
September 06 2024Product Safety: Annaleise Conway Presents on Sunscreen Testing at PCPC Symposium
Press Release
October 25 2021- PFAS
- Product Stewardship
- Pharmaceutical Risk and Toxicology
- Human Health Risk Assessment
- Ecological Risk Assessment
- Litigation Support